BLCO (Bausch & Lomb) Insider Ownership: 0.99 % (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BLCO Bausch & Lomb Corp BLCO
76 GF Score
Price $17.15
GF Value $17.95
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Bausch & Lomb Insider Ownership?

Bausch & Lomb BLCO +0.12% 76 Insider Ownership is 0.99 % as of Aug. 30, 2026. GuruFocus rates BLCO with a GF Score™ of 76/100 and a GF Value™ of $17.95 (Fairly Valued). The stock has 7 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bausch & Lomb's insider ownership is 0.99%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bausch & Lomb's Institutional Ownership is 10.82%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bausch & Lomb's Float Percentage Of Total Shares Outstanding is 12.77%.

Bausch & Lomb Insider Ownership Historical Data

* Premium members only.

The historical data trend for Bausch & Lomb's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch & Lomb Insider Ownership Chart

Bausch & Lomb Historical Data

The historical data trend for Bausch & Lomb can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 0.80 0.82 0.82 0.82 0.82 0.82 1.01 0.99 0.99 0.99
BLCO
76GF Score
Bausch & Lomb Corp BLCO
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch & Lomb Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.99 % mean?
Bausch & Lomb (BLCO) has a Insider Ownership of 0.99 % as of Aug. 30, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Bausch & Lomb and its competitors.
Is Bausch & Lomb's Insider Ownership too high?
Bausch & Lomb's current Insider Ownership is 0.99 %. Overall, Bausch & Lomb has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bausch & Lomb's Insider Ownership compare to ISRG and BDX?
Bausch & Lomb's Insider Ownership of 0.99 % can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Devices & Instruments company?
A good Insider Ownership depends on the Medical Devices & Instruments industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Bausch & Lomb and its competitors. Bausch & Lomb's current Insider Ownership is 0.99 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch & Lomb stock overvalued right now?
Based on GuruFocus' analysis, Bausch & Lomb (BLCO) is currently considered Fairly Valued. The stock's GF Value™ is $17.95, compared to a current price of $17.15 — trading 4.5% below its estimated fair value. The current Insider Ownership is 0.99 %. Bausch & Lomb's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Bausch & Lomb (BLCO), the current Insider Ownership is 0.99 % as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch & Lomb (BLCO) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch & Lomb stock appears to be undervalued. The current stock price of $17.15 is trading 4.5% below its estimated GF Value™ of $17.95. GuruFocus considers Bausch & Lomb to be Fairly Valued.

Key valuation signals for BLCO:

  • Insider Ownership: 0.99 %
  • GF Value™: $17.95 vs. price of $17.15 (4.5% below fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the BLCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch & Lomb Business Description

Other Exchanges S2L:GermanyBLCO:Canada
Address 520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
76GF Score

Get the complete analysis for BLCO

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.15
Price
$17.95
GF Value